AngioDynamics Gets FDA Clearance For Pulmonary Embolism Treatment
By Will Feuer AngioDynamics said the U.S. Food and Drug Administration has cleared its AlphaVac F18 system for the treatment of pulmonary embolism, a kind of blood clot that the company...
Source: marketscreener.com